Proteomics

Dataset Information

0

A methylotrophic bacterium growing with the antidiabetic drug metformin as its sole carbon, nitrogen and energy source


ABSTRACT: Metformin is one of the most prescribed antidiabetic agents worldwide, and also considered for other therapeutic applications including cancer and endocrine disorders. Metformin is largely unmetabolised by human enzymes, and its mechanisms of action, likely also involving the microbiome, are not yet well characterised. Increasing presence of metformin in the environment has raised concerns, with reported toxic effects on aquatic life and potentially also on humans. We report on the isolation and characterisation of strain MD1, an aerobic methylotrophic bacterium growing with metformin as its sole carbon, nitrogen and energy source. Sequence analysis of its fully assembled genome allows its affiliation to Aminobacter niigataensis. Strain MD1 degrades metformin into dimethylamine used for growth, leaving guanylurea as a side-product. Differential proteomics and transcriptomics, as well as minitransposon mutagenesis of the strain, point to genes and proteins potentially associated with hydrolytic C-N cleavage of metformin, transport of metformin and guanylurea, and associated regulatory processes. Our results will inform future research on the fate of metformin and its degradation products in the human gut and the environment, and to identify microbial players and enzymes involved in the transformation of pharmaceuticals.

INSTRUMENT(S): Q Exactive

ORGANISM(S): Unclassified Aminobacter

SUBMITTER: Lauriane Kuhn  

LAB HEAD: Stéphane Vuilleumier

PROVIDER: PXD036621 | Pride | 2023-03-11

REPOSITORIES: Pride

Dataset's files

Source:
altmetric image

Publications

A Methylotrophic Bacterium Growing with the Antidiabetic Drug Metformin as Its Sole Carbon, Nitrogen and Energy Source.

Chaignaud Pauline P   Gruffaz Christelle C   Borreca Adrien A   Fouteau Stéphanie S   Kuhn Lauriane L   Masbou Jérémy J   Rouy Zoé Z   Hammann Philippe P   Imfeld Gwenaël G   Roche David D   Vuilleumier Stéphane S  

Microorganisms 20221121 11


Metformin is one of the most prescribed antidiabetic agents worldwide and is also considered for other therapeutic applications including cancer and endocrine disorders. It is largely unmetabolized by human enzymes and its presence in the environment has raised concern, with reported toxic effects on aquatic life and potentially also on humans. We report on the isolation and characterisation of strain MD1, an aerobic methylotrophic bacterium growing with metformin as its sole carbon, nitrogen an  ...[more]

Similar Datasets

2020-12-15 | PXD018987 | Pride
2022-10-14 | PXD037383 | Pride
2024-01-29 | PXD042384 | Pride
2024-01-18 | PXD043460 | Pride
2022-03-15 | PXD024708 | Pride
2019-07-13 | E-MTAB-7272 | biostudies-arrayexpress
2020-09-21 | PXD011579 | Pride
2016-07-03 | E-MTAB-3791 | biostudies-arrayexpress
2016-03-14 | E-GEOD-67018 | biostudies-arrayexpress
2010-05-16 | E-GEOD-15437 | biostudies-arrayexpress